ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
dementia, alzheimer disease, mild cognitive impairment, galantamine hydrobromide, memory disorders, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805969
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.